Cargando…
Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
The rapid development of CRISPR–Cas technologies brought a personalized and targeted treatment of genetic disorders into closer reach. To render CRISPR-based therapies precise and safe, strategies to confine the activity of Cas(9) to selected cells and tissues are highly desired. Here, we developed...
Autores principales: | Hoffmann, Mareike D, Aschenbrenner, Sabine, Grosse, Stefanie, Rapti, Kleopatra, Domenger, Claire, Fakhiri, Julia, Mastel, Manuel, Börner, Kathleen, Eils, Roland, Grimm, Dirk, Niopek, Dominik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648350/ https://www.ncbi.nlm.nih.gov/pubmed/30982889 http://dx.doi.org/10.1093/nar/gkz271 |
Ejemplares similares
-
Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein
por: Hoffmann, Mareike D, et al.
Publicado: (2020) -
Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9 target specificity
por: Aschenbrenner, Sabine, et al.
Publicado: (2020) -
TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus
por: Senís, Elena, et al.
Publicado: (2017) -
CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri
por: Oh, Jee-Hwan, et al.
Publicado: (2014) -
Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications
por: Labuhn, Maurice, et al.
Publicado: (2018)